{"id":417682,"date":"2021-01-20T08:03:22","date_gmt":"2021-01-20T13:03:22","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=417682"},"modified":"2021-01-20T08:03:22","modified_gmt":"2021-01-20T13:03:22","slug":"catalyst-biosciences-announces-poster-presentations-at-the-eahad-2021-virtual-congress","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-biosciences-announces-poster-presentations-at-the-eahad-2021-virtual-congress\/","title":{"rendered":"Catalyst Biosciences Announces Poster Presentations at the EAHAD 2021 Virtual Congress"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SOUTH SAN FRANCISCO, Calif., Jan.  20, 2021  (GLOBE NEWSWIRE) &#8212; Catalyst Biosciences, Inc. (NASDAQ: CBIO), today announced two e-poster presentations at the European Association for Haemophilia and Allied Disorders (EAHAD) Virtual Congress being held on February 3 &#8211; 5, 2021.<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td colspan=\"3\">\n            <strong>Poster presentation details<\/strong><br \/>\n            \n          <\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:4%;width:4%;min-width:4%\">\u00a0<\/td>\n<td style=\"max-width:8%;width:8%;min-width:8%\">\u00a0<\/td>\n<td style=\"max-width:88%;width:88%;min-width:88%\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td>\u00a0<\/td>\n<td>Poster Title:\u00a0<\/td>\n<td>Subcutaneous Marzeptacog Alfa (Activated) is effective for on-demand treatment of spontaneous bleeding in hemophilia A rats<\/td>\n<\/tr>\n<tr>\n<td>\u00a0<\/td>\n<td>Presenter:\u00a0 \u00a0 \u00a0 \u00a0\u00a0<\/td>\n<td>Tom Knudsen, DVM, Ph.D., vice president of translational research, Catalyst Biosciences<\/td>\n<\/tr>\n<tr>\n<td>\u00a0<\/td>\n<td>Program number:\u00a0<\/td>\n<td>ABS027<\/td>\n<\/tr>\n<tr>\n<td>\u00a0<\/td>\n<td>Date\/Time:<\/td>\n<td>Poster available starting at 6 pm CET on February 2, through August 5, 2021<\/td>\n<\/tr>\n<tr>\n<td>\u00a0<\/td>\n<td>\u00a0<\/td>\n<td>\u00a0<\/td>\n<\/tr>\n<tr>\n<td>\u00a0<\/td>\n<td>Poster Title:<\/td>\n<td>Subcutaneous Marzeptacog Alfa (Activated) is effective for on-demand treatment of spontaneous bleeding in dogs with Hemophilia A<\/td>\n<\/tr>\n<tr>\n<td>\u00a0<\/td>\n<td>Presenter:<\/td>\n<td>Howard Levy, M.B.B.Ch., Ph.D., M.M.M., chief medical officer, Catalyst Biosciences<\/td>\n<\/tr>\n<tr>\n<td>\u00a0<\/td>\n<td>Program number:\u00a0\u00a0<\/td>\n<td>ABS028<\/td>\n<\/tr>\n<tr>\n<td>\u00a0<\/td>\n<td>Date\/Time:<\/td>\n<td>Poster available starting at 6 pm CET on February 2, through August 5, 2021<\/td>\n<\/tr>\n<\/table>\n<p>A copy of the presentation materials can be accessed on the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZBfiX81iPrEz2GKzjHhbRs0C-gZ_elWj3bMozFz9oSR9uokwyIg3G6IlRLvB1kaCgq1LcxSOclg1cnqUGu7VOhF0yxV7bLv7nNW-ju3Odd2gwl0zI20_1WOGwLEK2rgXZx7Dv4n2imkU0go9SYbScNkDknPu-thfJJpepUp7ufI=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Events and Presentations<\/a> section of the Catalyst website (www.catalystbiosciences.com) once the presentations conclude.<\/p>\n<p align=\"justify\">\n        <strong>About Catalyst Biosciences, the Protease Medicines company<\/strong><br \/>\n        <br \/>Catalyst is a research and clinical development biopharmaceutical company focused on addressing unmet medical needs in rare disorders of the complement and coagulation systems. Our protease engineering platform has generated two late-stage clinical programs, including MarzAA, a subcutaneously (SQ) administered next-generation engineered coagulation Factor VIIa (FVIIa) for the treatment of episodic bleeding in subjects with rare bleeding disorders. Our complement pipeline includes a pre-clinical program partnered with Biogen for dry age-related macular degeneration, an improved complement factor I protease for SQ replacement therapy in patients with CFI deficiency and C4b-degraders designed to target disorders of the classical complement pathway as well as other complement programs in development.<\/p>\n<p align=\"justify\">\n        <strong>Forward-Looking Statements<\/strong><br \/>\n        <br \/>This press release contains forward-looking statements that involve substantial risks and uncertainties. Forward-looking statements include statements about Catalyst\u2019s product candidates and the benefits of its protease engineering platform. Actual results or events could differ materially from the plans, intentions, expectations and projections disclosed in the forward-looking statements. Various important factors could cause actual results or events to differ materially, including, but not limited to, the risk that trials and studies may be delayed as a result of COVID-19 and other factors, that trials may not have satisfactory outcomes, that additional human trials will not replicate the results from earlier trials, that potential adverse effects may arise from the testing or use of MarzAA, including the generation of neutralizing antibodies, the risk that costs required to develop or manufacture the Company\u2019s products will be higher than anticipated, including as a result of delays in trial enrollment, development and manufacturing resulting from COVID-19 and other factors, the risk that Biogen will terminate Catalyst\u2019s agreement, competition and other risks described in the \u201cRisk Factors\u201d section of the Company\u2019s quarterly report filed with the\u00a0Securities and Exchange Commission\u00a0on\u00a0November 5, 2020, and in other filings with the\u00a0Securities and Exchange Commission. The Company does not assume any obligation to update any forward-looking statements, except as required by law.<\/p>\n<p>\n        <strong>Contact:<\/strong><br \/>\n        <br \/>Ana Kapor<br \/>Catalyst Biosciences, Inc.<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Za4pd2mBhkE1RJLt8aZTwfUcnlN0DxHC4n2PRZ-dCnxWzJqI6ZjaP2u4AUzcgJprz8P6ICQj2l2W1S6HugH015yHvi5UbtTmd_Unt1JIEuI=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">investors@catbio.com<\/a>\u00a0<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEzODQ4NCMzOTIxODU4IzIwMjcyNzY=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/cac490b2-37e7-4f02-9fc9-0ab0d2472490\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SOUTH SAN FRANCISCO, Calif., Jan. 20, 2021 (GLOBE NEWSWIRE) &#8212; Catalyst Biosciences, Inc. (NASDAQ: CBIO), today announced two e-poster presentations at the European Association for Haemophilia and Allied Disorders (EAHAD) Virtual Congress being held on February 3 &#8211; 5, 2021. Poster presentation details \u00a0 \u00a0 \u00a0 \u00a0 Poster Title:\u00a0 Subcutaneous Marzeptacog Alfa (Activated) is effective for on-demand treatment of spontaneous bleeding in hemophilia A rats \u00a0 Presenter:\u00a0 \u00a0 \u00a0 \u00a0\u00a0 Tom Knudsen, DVM, Ph.D., vice president of translational research, Catalyst Biosciences \u00a0 Program number:\u00a0 ABS027 \u00a0 Date\/Time: Poster available starting at 6 pm CET on February 2, through August 5, 2021 \u00a0 \u00a0 \u00a0 \u00a0 Poster Title: Subcutaneous Marzeptacog Alfa (Activated) is effective for on-demand treatment of spontaneous bleeding in &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-biosciences-announces-poster-presentations-at-the-eahad-2021-virtual-congress\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Catalyst Biosciences Announces Poster Presentations at the EAHAD 2021 Virtual Congress&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-417682","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Catalyst Biosciences Announces Poster Presentations at the EAHAD 2021 Virtual Congress - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-biosciences-announces-poster-presentations-at-the-eahad-2021-virtual-congress\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Catalyst Biosciences Announces Poster Presentations at the EAHAD 2021 Virtual Congress - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SOUTH SAN FRANCISCO, Calif., Jan. 20, 2021 (GLOBE NEWSWIRE) &#8212; Catalyst Biosciences, Inc. (NASDAQ: CBIO), today announced two e-poster presentations at the European Association for Haemophilia and Allied Disorders (EAHAD) Virtual Congress being held on February 3 &#8211; 5, 2021. Poster presentation details \u00a0 \u00a0 \u00a0 \u00a0 Poster Title:\u00a0 Subcutaneous Marzeptacog Alfa (Activated) is effective for on-demand treatment of spontaneous bleeding in hemophilia A rats \u00a0 Presenter:\u00a0 \u00a0 \u00a0 \u00a0\u00a0 Tom Knudsen, DVM, Ph.D., vice president of translational research, Catalyst Biosciences \u00a0 Program number:\u00a0 ABS027 \u00a0 Date\/Time: Poster available starting at 6 pm CET on February 2, through August 5, 2021 \u00a0 \u00a0 \u00a0 \u00a0 Poster Title: Subcutaneous Marzeptacog Alfa (Activated) is effective for on-demand treatment of spontaneous bleeding in &hellip; Continue reading &quot;Catalyst Biosciences Announces Poster Presentations at the EAHAD 2021 Virtual Congress&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-biosciences-announces-poster-presentations-at-the-eahad-2021-virtual-congress\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-20T13:03:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEzODQ4NCMzOTIxODU4IzIwMjcyNzY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/catalyst-biosciences-announces-poster-presentations-at-the-eahad-2021-virtual-congress\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/catalyst-biosciences-announces-poster-presentations-at-the-eahad-2021-virtual-congress\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Catalyst Biosciences Announces Poster Presentations at the EAHAD 2021 Virtual Congress\",\"datePublished\":\"2021-01-20T13:03:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/catalyst-biosciences-announces-poster-presentations-at-the-eahad-2021-virtual-congress\\\/\"},\"wordCount\":513,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/catalyst-biosciences-announces-poster-presentations-at-the-eahad-2021-virtual-congress\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEzODQ4NCMzOTIxODU4IzIwMjcyNzY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/catalyst-biosciences-announces-poster-presentations-at-the-eahad-2021-virtual-congress\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/catalyst-biosciences-announces-poster-presentations-at-the-eahad-2021-virtual-congress\\\/\",\"name\":\"Catalyst Biosciences Announces Poster Presentations at the EAHAD 2021 Virtual Congress - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/catalyst-biosciences-announces-poster-presentations-at-the-eahad-2021-virtual-congress\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/catalyst-biosciences-announces-poster-presentations-at-the-eahad-2021-virtual-congress\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEzODQ4NCMzOTIxODU4IzIwMjcyNzY=\",\"datePublished\":\"2021-01-20T13:03:22+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/catalyst-biosciences-announces-poster-presentations-at-the-eahad-2021-virtual-congress\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/catalyst-biosciences-announces-poster-presentations-at-the-eahad-2021-virtual-congress\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/catalyst-biosciences-announces-poster-presentations-at-the-eahad-2021-virtual-congress\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEzODQ4NCMzOTIxODU4IzIwMjcyNzY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEzODQ4NCMzOTIxODU4IzIwMjcyNzY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/catalyst-biosciences-announces-poster-presentations-at-the-eahad-2021-virtual-congress\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Catalyst Biosciences Announces Poster Presentations at the EAHAD 2021 Virtual Congress\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Catalyst Biosciences Announces Poster Presentations at the EAHAD 2021 Virtual Congress - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-biosciences-announces-poster-presentations-at-the-eahad-2021-virtual-congress\/","og_locale":"en_US","og_type":"article","og_title":"Catalyst Biosciences Announces Poster Presentations at the EAHAD 2021 Virtual Congress - Market Newsdesk","og_description":"SOUTH SAN FRANCISCO, Calif., Jan. 20, 2021 (GLOBE NEWSWIRE) &#8212; Catalyst Biosciences, Inc. (NASDAQ: CBIO), today announced two e-poster presentations at the European Association for Haemophilia and Allied Disorders (EAHAD) Virtual Congress being held on February 3 &#8211; 5, 2021. Poster presentation details \u00a0 \u00a0 \u00a0 \u00a0 Poster Title:\u00a0 Subcutaneous Marzeptacog Alfa (Activated) is effective for on-demand treatment of spontaneous bleeding in hemophilia A rats \u00a0 Presenter:\u00a0 \u00a0 \u00a0 \u00a0\u00a0 Tom Knudsen, DVM, Ph.D., vice president of translational research, Catalyst Biosciences \u00a0 Program number:\u00a0 ABS027 \u00a0 Date\/Time: Poster available starting at 6 pm CET on February 2, through August 5, 2021 \u00a0 \u00a0 \u00a0 \u00a0 Poster Title: Subcutaneous Marzeptacog Alfa (Activated) is effective for on-demand treatment of spontaneous bleeding in &hellip; Continue reading \"Catalyst Biosciences Announces Poster Presentations at the EAHAD 2021 Virtual Congress\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-biosciences-announces-poster-presentations-at-the-eahad-2021-virtual-congress\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-20T13:03:22+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEzODQ4NCMzOTIxODU4IzIwMjcyNzY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-biosciences-announces-poster-presentations-at-the-eahad-2021-virtual-congress\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-biosciences-announces-poster-presentations-at-the-eahad-2021-virtual-congress\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Catalyst Biosciences Announces Poster Presentations at the EAHAD 2021 Virtual Congress","datePublished":"2021-01-20T13:03:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-biosciences-announces-poster-presentations-at-the-eahad-2021-virtual-congress\/"},"wordCount":513,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-biosciences-announces-poster-presentations-at-the-eahad-2021-virtual-congress\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEzODQ4NCMzOTIxODU4IzIwMjcyNzY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-biosciences-announces-poster-presentations-at-the-eahad-2021-virtual-congress\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-biosciences-announces-poster-presentations-at-the-eahad-2021-virtual-congress\/","name":"Catalyst Biosciences Announces Poster Presentations at the EAHAD 2021 Virtual Congress - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-biosciences-announces-poster-presentations-at-the-eahad-2021-virtual-congress\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-biosciences-announces-poster-presentations-at-the-eahad-2021-virtual-congress\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEzODQ4NCMzOTIxODU4IzIwMjcyNzY=","datePublished":"2021-01-20T13:03:22+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-biosciences-announces-poster-presentations-at-the-eahad-2021-virtual-congress\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-biosciences-announces-poster-presentations-at-the-eahad-2021-virtual-congress\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-biosciences-announces-poster-presentations-at-the-eahad-2021-virtual-congress\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEzODQ4NCMzOTIxODU4IzIwMjcyNzY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEzODQ4NCMzOTIxODU4IzIwMjcyNzY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-biosciences-announces-poster-presentations-at-the-eahad-2021-virtual-congress\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Catalyst Biosciences Announces Poster Presentations at the EAHAD 2021 Virtual Congress"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/417682","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=417682"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/417682\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=417682"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=417682"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=417682"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}